ACADIA Pharmaceuticals (ACAD) Competitor Comparison
We are evaluating the key criteria listed to compare ACADIA Pharmaceuticals (ACAD) against its competitors in the Biotechnology industry.
Market Capitalization
40 / 368Gross Profits
40 / 278Total Revenue
22 / 300EBITDA
243 / 337Free Cashflow
200 / 352Quick Ratio
287 / 357Earnings per Share
27 / 359Dividend yield
0 / 6Total Cash
93 / 358Performance 3 years
136 / 368Performance 5 years
185 / 368Performance 10 years
141 / 368Linearity 3 years
53 / 368Linearity 5 years
147 / 368Linearity 10 years
74 / 367Total Rank
107 / 368Dividend Rank
325 / 368Valuation Rank
130 / 368Piotroski Rank
161 / 368Muliplier Rank
250 / 368Market Capitalization - ACAD ranking 40 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.